Latest California Healthline Stories
Kathy Brandt and Kim Acquaviva are both leaders in the world of hospice and palliative care. When Brandt learned she was dying of ovarian cancer, the couple decided it could be a teachable moment.
When an undocumented immigrant in a Texas border county gets a cancer diagnosis, it can be a death sentence because of a lack of public hospitals.
The main ingredient in numerous popular herbicides has been implicated by two juries in the cancers of frequent users, but major public health agencies disagree over whether it is a carcinogen. Can you use it safely in your garden? Here are some answers to questions you may have about the weed killer glyphosate.
Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
A growing number of community hospitals are forming alliances with some of the nation’s biggest and most prestigious institutions. But for prospective patients, it can be hard to assess what these relationships actually mean.
Breast implants — used for both cancer and cosmetic surgeries — give a glimpse into how hospitals mark up prices of medical devices to increase their bottom lines.
And new study finds no reason to get routine vitamin D tests, researchers say.